ATE496129T1 - Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide - Google Patents

Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide

Info

Publication number
ATE496129T1
ATE496129T1 AT04778867T AT04778867T ATE496129T1 AT E496129 T1 ATE496129 T1 AT E496129T1 AT 04778867 T AT04778867 T AT 04778867T AT 04778867 T AT04778867 T AT 04778867T AT E496129 T1 ATE496129 T1 AT E496129T1
Authority
AT
Austria
Prior art keywords
ssx
hla class
molecules
peptides
peptides presented
Prior art date
Application number
AT04778867T
Other languages
English (en)
Inventor
Danila Ludwig Valmori
Maha Ayyoub
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE496129T1 publication Critical patent/ATE496129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04778867T 2003-07-22 2004-07-21 Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide ATE496129T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48925703P 2003-07-22 2003-07-22
PCT/US2004/023544 WO2005010190A1 (en) 2003-07-22 2004-07-21 Ssx-2 peptides presented by hla class ii molucules

Publications (1)

Publication Number Publication Date
ATE496129T1 true ATE496129T1 (de) 2011-02-15

Family

ID=34102841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04778867T ATE496129T1 (de) 2003-07-22 2004-07-21 Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide

Country Status (5)

Country Link
US (2) US7910696B2 (de)
EP (1) EP1644501B1 (de)
AT (1) ATE496129T1 (de)
DE (1) DE602004031116D1 (de)
WO (1) WO2005010190A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138568A2 (en) 2005-06-17 2006-12-28 Mannkind Corporation Multivalent entrain-and-amplify immunotherapeutics for carcinoma
EP2222456B1 (de) * 2007-12-11 2014-07-02 Toray Plastics (America) , Inc. Verfahren zur herstellung einer biaxial orientierten polymilchsäurefolie mit hohen querorientierungsraten
CN102869682B (zh) * 2009-11-18 2016-10-19 曼康公司 单克隆抗体及其诊断用途
CN103124740B (zh) * 2010-09-21 2015-09-02 美国卫生和人力服务部 抗-ssx-2t细胞受体和相关材料及使用方法
CN105293806B (zh) * 2015-11-13 2017-11-21 中蓝连海设计研究院 一种t酸离析母液废水的综合治理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414580D0 (en) * 1994-07-19 1994-09-07 Cancer Res Campaign Tech Materials and methods relating to the diagnosis of synovial sarcomas
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US6548064B1 (en) * 1997-05-05 2003-04-15 Ludwig Institute For Cancer Research Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
US6291430B1 (en) 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US6140050A (en) * 1998-06-26 2000-10-31 Ludwig Institute For Cancer Research Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
US6800730B1 (en) 1998-10-02 2004-10-05 Ludwig Institute For Cancer Research Isolated peptides which bind to MHC class II molecules, and uses thereof
NZ521715A (en) * 2000-04-28 2008-01-31 Mannkind Corp Method of identifying and producing antigen peptides and use thereof as vaccines
WO2003008537A2 (en) 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences

Also Published As

Publication number Publication date
EP1644501A1 (de) 2006-04-12
US7910696B2 (en) 2011-03-22
US20060189001A1 (en) 2006-08-24
US20110144186A1 (en) 2011-06-16
EP1644501B1 (de) 2011-01-19
WO2005010190A1 (en) 2005-02-03
US9200047B2 (en) 2015-12-01
DE602004031116D1 (de) 2011-03-03

Similar Documents

Publication Publication Date Title
WO2002095051A3 (en) Mage-a3 peptides presented by hla class ii molecules
ZA988124B (en) Mage-3 peptides presented by HLA class II molecules
ATE427354T1 (de) Mage-a3 polypeptide die durch hla-klasse ii molekule prasentiert werden
CY1122250T1 (el) Αντισωματα που κατευθυνονται εναντι her-3 και χρησεις αυτων
CY1117786T1 (el) Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων
PH12019500122A1 (en) Bispecific antibody-like binding proteins specifically binding to cd3 and cd123
DE602004022922D1 (de) Peptide fähig die Dimerisierung von c-Jun zu inhibieren
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
DE60335000D1 (de) In vitro peptid-expressionsbank
WO2004113500A3 (en) B7s1: an immune modulator
MX2021010837A (es) Receptores en linfocitos t de la proteina 1 de tumor de wilms (wt1) de alta avidez.
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
ATE496129T1 (de) Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide
MXPA05006034A (es) Proteina de duplicacion.
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2005079490A3 (en) Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides
GB0324656D0 (en) A protein involved in ovarian cancer
ATE417112T1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
WO2003020887A3 (en) Gene identification
DE602005021159D1 (de) Bakteriophagen- und prophagen-proteine in der krebsgentherapie
WO2004078918A3 (en) Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
WO2003087408A3 (en) Schizophrenia associated genes
MX2023004020A (es) Anticuerpos anti-ngf y métodos para su uso.
TR201909281T4 (tr) HER-3'e yönelik antikorlar ve bunların kullanımı.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1644501

Country of ref document: EP